Less Ads, More Data, More Tools Register for FREE

Pin to quick picksPageGroup Regulatory News (PAGE)

Share Price Information for PageGroup (PAGE)

Share Price is delayed by 15 minutes
Get Live Data
122.60    -3.20 (-2.54%)
Bid:
122.20
Ask:
122.50
Spread: 0.30 (0.245%)
Market Cap: £381.73m
PAGE Live PriceLast checked at - London Stock Exchange

Intraday PageGroup Share Chart

EPT Disclosure

4 Sep 2008 11:52

RNS Number : 7456C
Deutsche Bank AG
04 September 2008
Β 

ο»Ώ

FORM 38.5(a)

DEALINGS BYΒ CONNECTED EXEMPT PRINCIPAL TRADERSΒ 

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(RuleΒ 38.5(a)Β ofΒ theΒ TakeoverΒ Code)

1. KEY INFORMATION

Name ofΒ exempt principal trader

Deutsche Bank AGΒ London

Company dealt in

Adecco

Class of relevant security to which the dealings being disclosed relateΒ (Note 1)

Ordinary

Date of dealing

03/09/2008

2. DEALINGSΒ (Note 2)

(a) Purchases and sales

Total number of securities purchased

Highest price paidΒ (Note 3)

CHF

Lowest price paidΒ (Note 3)

CHF

126,069

52.9

51.75

Total number of securities sold

Highest price paidΒ (Note 3)

CHF

Lowest price paidΒ (Note 3)

CHF

81,571

52.6

51.7

(b) Derivatives transactions (other than options)

Product name,Β 

e.g. CFD

Long/shortΒ (Note 4)

Number of securitiesΒ (Note 5)

Price per unitΒ (Note 3)

GBP

CFD

Long

158

51.952741

CFD

Short

11,296

52.083224

CFD

Short

8,490

52.217972

CFD

Short

5,162

52.3079

CFD

Short

1,385

52.398023

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.Β callΒ option

Writing, selling, purchasing, varying etc.

Number of securitiesΒ to which the option relatesΒ (Note 5)

Exercise

priceΒ 

Type, e.g. American, European etc.

ExpiryΒ 

Date

Option money

paid/receivedΒ per unitΒ (Note 3)

(ii) Exercising

Product name, e.g.Β call option

Number of securitiesΒ 

Exercise priceΒ per unitΒ (Note 3)

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form orΒ relating to the voting rights orΒ future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Date of disclosure

04/09/2008

Contact name

Artie Movsesian

Telephone number

020 7545 7804

Name ofΒ offeree/offeror with which connected

Michael Page International Plc

Nature of connectionΒ (NoteΒ 6)

Connected Advisor to Offeree

Notes

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's websiteΒ atΒ www.thetakeoverpanel.org.uk

Β Β Β FORM 38.5(a)

DEALINGS BYΒ CONNECTED EXEMPT PRINCIPAL TRADERSΒ 

WITH RECOGNISED INTERMEDIARY STATUS

DEALING IN A CLIENT-SERVING CAPACITY

(RuleΒ 38.5(a)Β ofΒ theΒ TakeoverΒ Code)

1. KEY INFORMATION

Name ofΒ exempt principal trader

Deutsche Bank AGΒ London

Company dealt in

Michael International Page International Plc

Class of relevant security to which the dealings being disclosed relateΒ (Note 1)

Ordinary

Date of dealing

03/09/2008

2. DEALINGSΒ (Note 2)

(a) Purchases and sales

Total number of securities purchased

Highest price paidΒ (Note 3)

GBP

Lowest price paidΒ (Note 3)

GBP

136,670

3.59858

3.49

Total number of securities sold

Highest price paidΒ (Note 3)

GBP

Lowest price paidΒ (Note 3)

GBP

112,441

3.59

3.4925

(b) Derivatives transactions (other than options)

Product name,Β 

e.g. CFD

Long/shortΒ (Note 4)

Number of securitiesΒ (Note 5)

Price per unitΒ (Note 3)

GBP

CFD

Long

26,508

3.5585

CFD

Long

5,972

3.51894

CFD

Short

22,500

3.510709

CFD

Short

21,337

3.53176

CFD

Short

12,180

3.5166

CFD

Short

8,161

3.5059

CFD

Short

1,611

3.59858

(c) Options transactions in respect of existing securities

(i) Writing, selling, purchasing or varying

Product name,

e.g.Β callΒ option

Writing, selling, purchasing, varying etc.

Number of securitiesΒ to which the option relatesΒ (Note 5)

Exercise

priceΒ 

Type, e.g. American, European etc.

ExpiryΒ 

Date

Option money

paid/receivedΒ per unitΒ (Note 3)

(ii) Exercising

Product name, e.g.Β call option

Number of securitiesΒ 

Exercise priceΒ per unitΒ (Note 3)

3. OTHER INFORMATION

Agreements, arrangements or understandings relating to options or derivatives

Full details of any agreement, arrangement or understanding between the person disclosing and any other person relating to the voting rights of any relevant securities under any option referred to on this form orΒ relating to the voting rights orΒ future acquisition or disposal of any relevant securities to which any derivative referred to on this form is referenced. If none, this should be stated.

Date of disclosure

04/09/2008

Contact name

Artie Movsesian

Telephone number

020 7545 7804

Name ofΒ offeree/offeror with which connected

Michael Page International Plc

Nature of connectionΒ (NoteΒ 6)

Connected Advisor to Offeree

Notes

The Notes on Form 38.5(a) can be viewed on the Takeover Panel's websiteΒ atΒ www.thetakeoverpanel.org.uk

This information is provided by RNS
The company news service from the London Stock Exchange
Β 
END
Β 
Β 
EMMLIMMTMMAMBBP
Date   Source Headline
23rd Dec 20227:00 amRNSBoard Changes
18th Oct 20227:00 amRNSAppointment of Chief Executive Officer Designate
12th Oct 20227:00 amRNSThird Quarter 2022 Trading Update
11th Oct 20229:28 amRNSNotice of Third Quarter 2022 Trading Update
8th Aug 20227:00 amRNSHalf-year Report
3rd Aug 202212:13 pmRNSNotice of 2022 Half Year Results
13th Jul 20227:00 amRNSSecond Quarter 2022 Trading Update
7th Jul 202212:29 pmRNSNotice of Second Quarter 2022 Trading Update
31st May 20222:59 pmRNSResult of AGM
3rd May 20229:33 amRNSChange in Director's Details
20th Apr 202211:54 amRNSAnnual Report & Accounts & Notice of AGM
12th Apr 20227:00 amRNSCEO Succession
12th Apr 20227:00 amRNSFIRST QUARTER 2022 TRADING UPDATE
6th Apr 20223:21 pmRNSNotice of First Quarter 2022 Trading Update
6th Apr 202212:52 pmRNSChange in Director's Details
16th Mar 20221:22 pmRNSDirector/PDMR Shareholding
15th Mar 20222:04 pmRNSDirector/PDMR Shareholding
14th Mar 202212:00 pmRNSBoard changes
10th Mar 202211:00 amRNSDirector/PDMR Shareholding
3rd Mar 20227:00 amRNSFinal Results
24th Feb 20223:19 pmRNSNotice of 2021 Full Year Results
12th Jan 20227:00 amRNSFOURTH QUARTER AND FULL YEAR 2021 TRADING UPDATE
10th Jan 202212:41 pmRNSNotice of Q4 and Full Year 2021 Trading Update
24th Dec 20219:10 amRNSDirector/PDMR Shareholding
22nd Dec 20217:34 amRNSHolding(s) in Company
21st Dec 202111:02 amRNSAppointment of new Chair
9th Dec 20217:00 amRNS2021 Virtual Capital Markets Event
7th Dec 20217:00 amRNSTrading Update
18th Nov 20213:40 pmRNSHolding(s) in Company
20th Oct 20217:00 amRNSChair's retirement
15th Oct 20213:21 pmRNSDirector/PDMR Shareholding
6th Oct 20217:00 amRNSQ3 Trading Update
1st Sep 202110:30 amRNSChange in Director Details
9th Aug 20217:00 amRNSHalf Year Results for the Period Ended 30 June 21
5th Aug 20219:23 amRNSNotice of 2021 Half Year Results
12th Jul 20213:20 pmRNSHolding(s) in Company
7th Jul 20217:00 amRNSQ2 2021 TRADING UPDATE
3rd Jun 20211:42 pmRNSResult of AGM
21st May 20213:57 pmRNSDirector Declaration
21st May 20211:40 pmRNSDirector/PDMR Shareholding
28th Apr 20212:57 pmRNSHolding(s) in Company
20th Apr 20214:14 pmRNSAnnual Report and Accounts and Notice of AGM
9th Apr 20217:00 amRNSFirst Quarter 2021 Trading Update
1st Apr 20219:09 amRNSDirector Declaration
26th Mar 202110:45 amRNSHolding(s) in Company
24th Mar 20214:32 pmRNSDirector Declaration
17th Mar 202110:10 amRNSDirector/PDMR Shareholding
16th Mar 202112:41 pmRNSDirector/PDMR Shareholding
15th Mar 202112:23 pmRNSDirector/PDMR Shareholding
5th Mar 202112:03 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.